Profile data is unavailable for this security.
About the company
Wuhan Keqian Biology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of veterinary biological products, as well as the provision of animal disease prevention technology services. The main products include swine vaccines, poultry vaccines, pet vaccines and diagnostic reagents. The Company mainly operates its businesses in the domestic.
- Revenue in CNY (TTM)1.01bn
- Net income in CNY459.54m
- Incorporated2001
- Employees924.00
- LocationWuhan Keqian Biology Co LtdNo. 419, Gaoxin 2nd Road, DonghuNew Technology Development ZoneWUHAN 430073ChinaCHN
- Phone+86 2 781322905
- Fax+86 2 781322905
- Websitehttp://www.kqbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai OPM Biosciences Co Ltd | 352.91m | 43.24m | 7.03bn | 328.00 | 144.06 | 2.92 | -- | 19.91 | 0.3751 | 0.3751 | 3.18 | 18.51 | 0.1558 | 2.50 | 4.05 | 1,075,953.00 | 1.88 | 3.50 | 1.96 | 3.69 | 50.40 | 57.44 | 12.09 | 21.40 | 15.47 | -- | 0.0272 | 58.30 | 22.26 | 38.41 | -61.04 | -- | 43.46 | -- |
| Jiangsu Aidea Pharmaceutical Group Co Ld | 671.33m | -87.10m | 7.19bn | 704.00 | -- | 7.35 | -- | 10.71 | -0.207 | -0.207 | 1.60 | 2.32 | 0.3558 | 1.01 | 4.33 | 953,592.70 | -3.23 | -4.33 | -5.23 | -5.36 | 63.08 | 40.16 | -9.09 | -20.35 | 1.03 | -2.12 | 0.3093 | -- | 1.57 | 3.89 | -85.63 | -- | 5.88 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 711.63m | -62.67m | 7.27bn | 925.00 | -- | 4.08 | -- | 10.22 | -0.0605 | -0.0605 | 0.6865 | 2.18 | 0.2795 | 2.02 | 2.18 | 769,331.60 | -2.47 | 5.01 | -2.70 | 6.20 | 88.90 | 91.92 | -8.83 | 14.50 | 8.51 | -11.45 | 0.007 | 48.29 | -16.61 | -7.17 | -63.42 | -29.45 | 1.11 | -- |
| Wuhan Keqian Biology Co Ltd | 1.01bn | 459.54m | 7.64bn | 924.00 | 16.74 | 1.83 | -- | 7.54 | 0.9796 | 0.9796 | 2.16 | 8.95 | 0.2209 | 2.86 | 3.23 | 1,097,706.00 | 9.97 | 11.71 | 11.17 | 13.56 | 65.26 | 73.57 | 45.16 | 44.51 | 5.02 | -- | 0.0017 | 32.23 | -11.48 | 13.17 | -3.43 | 9.52 | -4.93 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.78bn | 214.11m | 7.72bn | 3.63k | 35.95 | 1.84 | -- | 2.04 | 0.2112 | 0.2112 | 3.72 | 4.12 | 0.633 | 3.37 | 7.63 | 1,040,448.00 | 4.45 | 0.7994 | 6.29 | 5.29 | 51.41 | 23.96 | 7.02 | 3.71 | 3.96 | -- | 0.0393 | 43.21 | -13.02 | -17.29 | -19.73 | -6.70 | 21.16 | 0.00 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 1.60bn | -332.62m | 7.89bn | 2.35k | -- | 1.08 | -- | 4.95 | -0.3545 | -0.3545 | 1.70 | 7.75 | 0.1303 | 0.6358 | 0.4977 | 679,399.90 | -2.74 | 3.29 | -3.80 | 4.46 | 44.16 | 37.24 | -21.03 | 10.59 | 1.33 | -1.45 | 0.3114 | 24.43 | -13.90 | -3.87 | -7.30 | 1.41 | 1.13 | -7.12 |
| Cisen Pharmaceutical Co Ltd | 3.56bn | 492.80m | 7.96bn | 3.30k | 16.21 | 1.29 | -- | 2.23 | 1.08 | 1.08 | 7.84 | 13.59 | 0.472 | 2.10 | 5.34 | 1,079,074.00 | 6.58 | 6.51 | 8.12 | 8.07 | 53.70 | 55.92 | 13.94 | 10.84 | 3.48 | -- | 0.0069 | 37.16 | -10.77 | -0.6464 | -2.38 | -0.2215 | -0.3051 | 10.42 |
| China Animal Husbandry Industry Co., Ltd | 6.28bn | 214.44m | 7.98bn | 4.30k | 37.19 | 1.39 | -- | 1.27 | 0.21 | 0.21 | 6.15 | 5.60 | 0.6863 | 5.30 | 4.19 | 1,461,064.00 | 2.32 | 5.25 | 3.37 | 7.48 | 15.59 | 22.15 | 3.38 | 7.31 | 1.62 | -- | 0.1625 | 31.16 | 11.30 | 7.79 | -82.41 | -22.24 | -0.0699 | -21.83 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 751.12m | 184.84m | 8.20bn | 1.22k | 44.04 | 3.49 | -- | 10.91 | 0.2241 | 0.2241 | 0.8963 | 2.83 | 0.2472 | 0.9248 | 3.00 | 616,180.10 | 6.08 | 8.91 | 7.77 | 12.10 | 51.51 | 53.44 | 24.61 | 27.68 | 2.17 | -- | 0.1383 | 27.35 | -2.63 | 20.90 | -18.55 | 29.68 | 17.53 | 43.79 |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.29bn | -363.56m | 8.22bn | 2.97k | -- | 1.42 | -- | 3.58 | -0.1112 | -0.1112 | 0.7189 | 1.82 | 0.204 | 2.09 | 3.30 | 771,487.60 | -4.90 | -0.1745 | -7.79 | -0.2739 | 34.13 | 64.36 | -24.05 | -0.6631 | 2.01 | -5.26 | 0.2563 | 69.54 | -26.67 | -9.85 | -547.14 | -- | 4.41 | -- |
Data as of Feb 11 2026. Currency figures normalised to Wuhan Keqian Biology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 985.66k | 0.21% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 972.15k | 0.21% |
| Taiping Fund Management Co., Ltd.as of 30 Jun 2025 | 600.00k | 0.13% |
| Arrowstreet Capital LPas of 31 Jan 2026 | 554.25k | 0.12% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 486.00k | 0.10% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2025 | 406.55k | 0.09% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 263.98k | 0.06% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 252.90k | 0.05% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2025 | 245.43k | 0.05% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 208.43k | 0.05% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
